#penalties

Briefing: Drug company penalties for paying kickbacks to doctors failed to dent bottom lines, analysis finds

Strategic angle: An analysis reveals that drugmakers penalized for kickbacks paid only a small fraction of their U.S. revenue from the drugs involved.